ABOUT EXPANDING OPTIONS FOR USING BALB/C NUDE MICE FOR EXPERIMENTAL STUDY OF HUMAN MALIGNANT TUMORS IN VIVO
https://doi.org/10.37748/2687-0533-2020-1-2-4
Abstract
The article has a problematic scripting nature. At the present stage, in addition to objective factors that make it difficult to create adequate experimental models of human oncogenesis, there is a significant backlog of domestic science in the development of this direction. This reduces the availability for Russian specialists of humanized immunodeficient animals corresponding to the level of research tasks. Based on the analysis of literature data, we discuss approaches that can expand the use of a widely available immunodeficiency animal model‑BALB/c nude mice. The possibility of using human mesenchymal stem cells that are not rejected by BALB/C Nude mice for local humanization of immunodeficient animals and improving the structural and functional characteristics of xenografts is considered. The possibility of obtaining xenografts of human glioblasts supported in the body of immunocompetent BALB/c mice after serial passages of organotypic tumor spheroids in the brain of BALB/c nude mice is analyzed.
About the Authors
G. V. Zhukova
National Medical Research Centre for Oncology of the Ministry of Health of Russia
Russian Federation
Russian Federation
Dr. Sci. (Biol.), Senior Researcher at the Testing Laboratory Center
SPIN: 1887–7415, AuthorID: 564827,
Scopus Author ID: 7005456284, Researcher ID: Y-4243–2016
63 14 line str., Rostov-on-Don 344037, Russian Federation
A. I. Shikhliarova
National Medical Research Centre for Oncology of the Ministry of Health of Russia
Russian Federation
Russian Federation
Dr. Sci. (Biol.), Professor, Senior Researcher at the Testing Laboratory Center
SPIN: 6271–0717, AuthorID: 482103, Scopus Author ID: 6507723229
63 14 line str., Rostov-on-Don 344037, Russian Federation
A. B. Sagakyants
National Medical Research Centre for Oncology of the Ministry of Health of Russia
Russian Federation
Russian Federation
Cand. Sci. (Biol.), Associate Professor, Head of the Tumor Immunophenotyping Laboratory
SPIN: 7272–1408, AuthorID: 426904,
Scopus Author ID: 24329773900, Researcher ID: M-8378–2019
63 14 line str., Rostov-on-Don 344037, Russian Federation
T. P. Protasova
National Medical Research Centre for Oncology of the Ministry of Health of Russia
Russian Federation
Russian Federation
Cand. Sci. (Biol.), Researcher at the Testing Laboratory Center
SPIN: 4542–3581, Author ID: 760427
63 14 line str., Rostov-on-Don 344037, Russian Federation
References
1. Williams JA. Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field. J Clin Med. 2018 Mar 2; 7(3): 41. https://doi.org/10.3390/jcm7030041
2. De La Rochere P, Guil‑Luna S, Decaudin D, Azar G, Sidhu SS, Piaggio E. Humanized Mice for the Study of Immuno‑Oncology. Trends Immunol. 2018; 39(9): 748–763. https://doi.org/10.1016/j.it.2018.07.001
3. Wege AK. Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy. BioDrugs. 2018 Jun; 32(3): 245–266. https://doi.org/10.1007/s40259–018–0275–4
4. Huszthy PC, Daphu I, Niclou SP, Stieber D, Nigro JM, Sakariassen PØ, et al. In vivo models of primary brain tumors: pitfalls and perspectives. Neuro‑oncology. 2012 Aug; 14(8): 979–993. https://doi.org/10.1093/neuonc/nos135
5. Morton JJ, Bird G, Refaeli Y, Jimeno A. Humanized Mouse Xenograft Models: Narrowing the Tumor‑Microenvironment Gap. Cancer Res. 2016 Nov 01; 76(21): 6153–6158. https://doi.org/10.1158/0008–5472.CAN‑16–1260
6. Murayama T, Gotoh N. Patient‑Derived Xenograft Models of Breast Cancer and Their Application. Cells. 2019 Jun 20; 8(6): 621. https://doi.org/10.3390/cells8060621
7. Bracci L, Schiavoni G, Sistigu A, Belardelli F. Immune‑based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale‑based combined treatments against cancer. Cell Death Differ. 2014 Jan; 21(1): 15–25. https://doi.org/10.1038/cdd.2013.67
8. Huszthy PC, Sakariassen PØ, Espedal H, Brokstad KA, Bjerkvig R, Miletic H. Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression. PLoS ONE. 2015; 10(8): e0136089. https://doi.org/10.1371/journal.pone.0136089
9. Treshchalina EM. Immunodeficient mice balb/c nude and modeling of various types of tumor growth for preclinical studies. Russian Journal of Biotherapy. 2017; 16(3): 6–13. (In Russian). https://doi.org/10.17650/1726–9784–2017–16–3‑6–13
10. Tsoneva D, Minev B, Frentzen A, Zhang Q, Wege AK, Szalay AA. Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus‑Mediated Oncolysis. Mol Ther Oncolytics. 2017 Jun 16; 5: 41–61. https://doi.org/10.1016/j.omto.2017.03.001
11. Ridge SM, Sullivan FJ, Glynn SA. Mesenchymal stem cells: key players in cancer progression. Mol Cancer. 2017 Feb 1; 16(1): 31. https://doi.org/10.1186/s12943–017–0597–8
12. Wu C‑G, Zhang J‑C, Xie C‑Q, Parolini O, Silini A, Huang Y‑Z, et al. In vivo tracking of human placenta derived mesenchymal stem cells in nude mice via 14C‑TdR labeling. BMC Biotechnol. 2015 Jun 13; 15: 55. https://doi.org/10.1186/s12896–015–0174–4
13. Chen P, Huang Y, Womer KL. Effects of mesenchymal stromal cells on human myeloid dendritic cell differentiation and maturation in a humanized mouse model. J Immunol Methods. 2015 Dec; 427: 100–104. https://doi.org/10.1016/j.jim.2015.10.008
14. Pacioni S, D’Alessandris QG, Giannetti S, Morgante L, Coccè V, Bonomi A, et al. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts. Stem Cell Res Ther. 2017 Mar 9; 8(1): 53. https://doi.org/10.1186/s13287–017–0516–3
15. Gao T, Yu Y, Cong Q, Wang Y, Sun M, Yao L, et al. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet‑activating factor. BMC Cancer. 2018 Oct 19; 18(1): 999. https://doi.org/10.1186/s12885–018–4918–0
16. Wabitsch S, Benzing C, Krenzien F, Splith K, Haber PK, Arnold A, et al. Human Stem Cells Promote Liver Regeneration After Partial Hepatectomy in BALB/C Nude Mice. Journal of Surgical Research. 2019 Jul 1; 239: 191–200. https://doi.org/10.1016/j.jss.2019.02.010
17. Soria B, Martin‑Montalvo A, Aguilera Y, Mellado‑Damas N, López‑Beas J, Herrera‑Herrera I, et al. Human Mesenchymal Stem Cells Prevent Neurological Complications of Radiotherapy. Front Cell Neurosci. 2019; 13: 204. https://doi.org/10.3389/fncel.2019.00204
18. Bajetto A, Pattarozzi A, Corsaro A, Barbieri F, Daga A, Bosio A, et al. Different effects of human umbilical cord mesenchymal stem cells on glioblastoma stem cells by direct cell interaction or via released soluble factors. Frontiers in Cellular Neuroscience. 2017 Oct 13; 11: 312. https://doi.org/10.3389/fncel.2017.00312
19. Li J‑H, Fan W‑S, Wang M–M, Wang Y‑H, Ren Z‑G. Effects of mesenchymal stem cells on solid tumor metastasis in experimental cancer models: a systematic review and meta‑analysis. J Transl Med. 2018 Apr 27; 16(1): 113. https://doi.org/10.1186/s12967–018–1484–9
20. DeRose YS, Wang G, Lin Y‑C, Bernard PS, Buys SS, Ebbert MTW, et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med. 2011 Oct 23; 17(11): 1514–1520. https://doi.org/10.1038/nm.2454
21. Bjerkvig R, Tønnesen A, Laerum OD, Backlund EO. Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg. 1990 Mar; 72(3): 463–475. https://doi.org/10.3171/jns.1990.72.3.0463
22. van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AAM, Voskuil DW, et al. A gene‑expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002 Dec 19; 347(25): 1999–2009. https://doi.org/0.1056/NEJMoa021967
23. Naus CC, Aftab Q, Sin WC. Common mechanisms linking connexin43 to neural progenitor cell migration and glioma invasion. Seminars in Cell & Developmental Biology. 2016 Feb 1; 50: 59–66. https://doi.org/10.1016/j.semcdb.2015.12.008
24. Sepiashvili RI. Immune system of the brain and spinal fluid. Allergology and Immunology. 2013; 14(4): 241–253. (In Russian).
Review
For citations:
Zhukova G.V., Shikhliarova A.I., Sagakyants A.B., Protasova T.P. ABOUT EXPANDING OPTIONS FOR USING BALB/C NUDE MICE FOR EXPERIMENTAL STUDY OF HUMAN MALIGNANT TUMORS IN VIVO. South Russian Journal of Cancer. 2020;1(2):28-35. https://doi.org/10.37748/2687-0533-2020-1-2-4
Views:
1035
Email this article 